Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV

By sjmartinez • January 2, 2025

Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe A, Nagaddya B, Naidoo M, Hoffman RM, Lockman S; IMPAACT 2010/VESTED Study Team. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. J Acquir Immune Defic Syndr. 2024 Oct;97(2):150-155. doi: 10.1097/qai.0000000000003473. PMID: 39742354; PMCID: PMC11684739.

Tags: Conception on antiretroviral therapy, high rates adverse outcomes, Infectious Diseases, interpregnancy interval, pregnancy outcomes, prior pregnancy loss, Publications, Women living with HIV

High HBV Seroprotection Rates in Infants Born to People with HIV and HBV Infection in Sub-Saharan Africa

Mohtashemi N, Spaczai J, Guo R, Tseng CH, Cambou MC, Emel L, Ship H, Zhang TH, Chiu SH, Stranix-Chibanda L, Chipato T, Kintu K, Manji[...]

Centering the voices of transwomen in HIV prevention

Clark J, Caceres C. Centering the voices of transwomen in HIV prevention. AIDS. 2025 Nov 15;39(14):2138-2139. doi: 10.1097/QAD.0000000000004354. Epub 2025 Oct 30. PMID: 41603875.

Mechanistic insights into the impact of prenatal viral infections on maternal and offspring immunity

Salem GM, Azamor T, Familiar-Macedo D, Onwubueke C, Cambou MC, Chen W, Nielsen-Saines K, Foo SS. Mechanistic insights into the impact of prenatal viral infections[...]